Guest guest Posted December 28, 2006 Report Share Posted December 28, 2006 Oh wow. Did I know about Dr. Zagon getting that grant?? How very cool and very exciting!! Challis Sharon Marsden wrote: I haven't talked about this much here and I don't really know why. I started taking LDN (Low Dose Naltrexone) a month ago. I started on 3 mg. and I am going to ask to go up to 3.5 mg and I'll see how that goes. Most ldn'ers say you must take it at night but it caused me too much sleep disturbances. About 1/3 of people who take LDN suffer sleep disturbances. With my leg pain at night I just couldn't handle it. So I take it in the morning. I have emailed with Dr. Ian Zagon and he says it doesn't make a difference when you take it and I believe him. Dr. Zagon just got a $40,000 grant from NMSS to study LDN. So what are my results? I feel better during the day. I have more stamina. And the biggie is that the severe nocturnal leg pain I've suffered with for over a year is better. The pain has decreased! It's not gone, but it's better. As a result I am sleeping sounder than I have in a long time and I'm dreaming again! I feel relaxed and refreshed when I wake up. I'm planning to stay on LDN. I have had a rough time of it MS-wise for the last year. I am 'cautiously optimistic' about LDN, I suppose is the way to put it. I am not on any of the CRAB drugs but I understand I could take Copaxone along with LDN but none of the other CRABs. I feel like I've just come out of the closet with my secret life.... ROFLhugs)))Sharon I was trying to daydream, but my mind kept wandering. <!--[if !supportLineBreakNewLine]--> <!--[endif]--> Need a quick answer? Get one in minutes from people who know. Ask your question on Yahoo! Answers. __________________________________________________ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.